Trial Profile
Relationship between skeletal muscle depletion and outcomes of Sorafenib treatment in patients with Hepatocellular carcinoma: a retrospective, cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Feb 2018 New trial record